New Patent Issued to Martek Protecting Lower Cost DHA
COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 2, 1998--Martek Biosciences Corp. (NASDAQ: MATK - news)
today announced that the U.S. Patent and Trademark Office has issued patent number 5,711,983 to the company
covering the composition of matter of its DHA-rich algal biomass.
Martek's algal biomass is the material from which the company derives its DHA oil.
''This patent is important because it protects an inexpensive source of DHA. Instead of processing Martek's
DHA-rich algal biomass into DHA-rich oil, the biomass has the potential to be ingested directly by humans,
commercial meat and egg producing animals, and fish,'' said Henry Linsert, Jr., Martek's chairman and CEO.
This press release contains forward-looking statements regarding the protection afforded by Martek's patents.
Such statements involve risks and uncertainties that could cause actual results to differ due to a variety of risk
factors set forth from time to time in the company's filings with the Securities and Exchange Commission,
including but not limited to its filed reports on Form 10-K, Form 10-Q and its Form S-3 declared effective on
Sept. 26, 1995.
Martek Biosciences Corp. develops, manufactures and sells products from microalgae. The company's products
include: (1) specialty, edible oils for infant formula, nutritional supplements and foods which play a central role in
the development of the eyes and central nervous system; (2) high value reagents to visualize molecular
interactions for drug discovery and development and; (3) new, powerful fluorescent markers for diagnostics,
rapid, miniaturized screening, and gene and protein detection.
Contact:
Martek Biosciences Corp.
Steve Dubin, chief financial officer
or
Gregg Lampf, corporate communications
410/740-0081 |
